The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharides
- 1 April 1987
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 243 (1), 31-37
- https://doi.org/10.1042/bj2430031
Abstract
The influence of Ca2+, phospholipid and Factor V was determined on the rate of inactivation of Factor Xa by antithrombin III, in the absence and in the presence of unfractionated heparin and of three high-affinity heparin oligosaccharides in the Mr range 1500-6000. In the absence of heparin the addition of Ca2+, phospholipid and Factor V caused a 4-fold decrease in rate of inactivation of Factor Xa. As concentrations of unfractionated heparin were increased the protective effect of Ca2+/phospholipid/Factor V was gradually abolished, and at a concentration of 2.4 nM there were no differences in rates of neutralization of Factor Xa in the presence or absence of Ca2+, phospholipid and Factor V. In contrast, heparin decasaccharide (Mr 3000) and pentasaccharide (Mr 1500) fragments were unable to overcome the protective effect of Ca2+/phospholipid/Factor V; in the presence of these components their catalytic efficiencies were 16-fold and 40-fold less respectively than that of unfractionated heparin. A heparin 20-22-saccharide fragment (Mr approx. 6000) gave similar inactivation rates in the presence and in the absence of Ca2+/phospholipid/Factor V. Human and bovine Factor Xa gave similar results. These results indicate that in the presence of Ca2+/phospholipid/Factor V optimum inhibition of Factor Xa requires a saccharide sequence of heparin additional to that involved in binding to antithrombin III. The use of free enzyme for the assessment of anti-(Factor Xa) activity of low-Mr heparin fractions could give misleading results.This publication has 39 references indexed in Scilit:
- Inhibition of prothrombinase complex by plasma proteinase inhibitorsBiochemistry, 1984
- Protection of factor Xa from neutralization by the heparin-antithrombin complex.JCI Insight, 1983
- Discordance between the anti-Xa activity and the antithrombotic activity of an ultra-low molecular weight heparin fractionThrombosis Research, 1982
- Preparation of a Stable Phospholipid Reagent for Coagulation AssaysPathophysiology of Haemostasis and Thrombosis, 1982
- Interactions between heparin and factor Xa inhibition of prothrombin activationBiochimica et Biophysica Acta (BBA) - General Subjects, 1979
- Anticoagulant Activities of High and Low Molecular Weight Heparin FractionsBritish Journal of Haematology, 1979
- Binding of bovine coagulation factor Xa to plateletsBiochemistry, 1978
- Characterization of human, bovine, and horse antithrombin IIIBiochemistry, 1976
- Factor‐Xa Inactivation by Antithrombin IIIBritish Journal of Haematology, 1973
- The Role of Platelets in Intrinsic Factor‐Xa FormationBritish Journal of Haematology, 1972